IVAX Corporation has entered into agreements with Gedeon Richter Ltd under which a number of generic drugs will be developed for the United States market and distributed exclusively by IVAX’ wholly-owned subsidiary, IVAX Pharmaceuticals, Inc. Dr. Rafick Henein, IVAX Pharmaceuticals, Inc.’s president and chief executive officer, said, “IVAX is very pleased with this new collaboration. Read more about Generic Collaboration For Ivax And Gedeon Richter[…]